AustralianSuper’s Insmed INSM Stock Holding History

AustralianSuper’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Buy	11,670 +1,665	+17%	+$256K	0.01%	235
2025 Q4	$1.74M	Buy	+10,005	New	+$1.83M	0.01%	231

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AustralianSuper's INSM Position: Q1 2026 in Review

AustralianSuper increased its Insmed (INSM) stake by 17% in Q1 2026, buying an estimated $256K and bringing the position to 11,670 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #235.

AustralianSuper first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

AustralianSuper held 11,670 shares of Insmed worth $1.91M as of Q1 2026.
AustralianSuper bought 1,665 Insmed shares in Q1 2026, an estimated $256K.
Insmed made up 0.01% of AustralianSuper's portfolio in Q1 2026, its #235 holding.
AustralianSuper first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.